Re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039

Eur Urol. 2015 Nov;68(5):e106-7. doi: 10.1016/j.eururo.2015.07.028. Epub 2015 Jul 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Male
  • Prostatic Neoplasms*
  • Risk Assessment*